New: Introducing “Why Is It Moving?” - lightning-fast, AI-driven explanations of stock moves

Learn More
Last Close
Oct 13  •  04:00PM ET
65.36
Dollar change
-1.30
Percentage change
-1.95
%
IndexS&P 500 P/E22.62 EPS (ttm)2.89 Insider Own5.84% Shs Outstand253.24M Perf Week-4.29%
Market Cap17.54B Forward P/E20.47 EPS next Y3.19 Insider Trans-0.37% Shs Float252.72M Perf Month-5.21%
Enterprise Value21.84B PEG4.08 EPS next Q0.88 Inst Own82.84% Short Float3.70% Perf Quarter-7.62%
Income778.00M P/S2.58 EPS this Y2.17% Inst Trans-0.62% Short Ratio3.70 Perf Half Y-13.98%
Sales6.79B P/B3.05 EPS next Y5.95% ROA5.88% Short Interest9.35M Perf YTD-14.27%
Book/sh21.44 P/C184.83 EPS next 5Y5.54% ROE13.92% 52W High86.24 -24.21% Perf Year-18.00%
Cash/sh0.35 P/FCF26.77 EPS past 3/5Y1.48% 2.22% ROIC8.78% 52W Low63.66 2.67% Perf 3Y-9.76%
Dividend Est.1.80 (2.75%) EV/EBITDA16.69 Sales past 3/5Y2.10% 4.69% Gross Margin38.22% Volatility2.59% 2.20% Perf 5Y-31.79%
Dividend TTM1.77 (2.71%) EV/Sales3.22 EPS Y/Y TTM-1.83% Oper. Margin15.98% ATR (14)1.43 Perf 10Y60.06%
Dividend Ex-DateOct 14, 2025 Quick Ratio0.29 Sales Y/Y TTM1.64% Profit Margin11.46% RSI (14)41.56 Recom2.33
Dividend Gr. 3/5Y7.30% 8.06% Current Ratio0.71 EPS Q/Q1.23% SMA20-1.45% Beta0.61 Target Price78.64
Payout57.44% Debt/Eq0.76 Sales Q/Q2.68% SMA50-4.47% Rel Volume0.91 Prev Close66.66
Employees14100 LT Debt/Eq0.54 EarningsOct 07 BMO SMA200-11.78% Avg Volume2.53M Price65.36
IPOMar 17, 1980 Option/ShortYes / Yes EPS/Sales Surpr.2.53% 0.56% Trades Volume2,309,264 Change-1.95%
Date Action Analyst Rating Change Price Target Change
Aug-20-25Upgrade JP Morgan Neutral → Overweight $83
Jun-16-25Initiated UBS Neutral $83
Mar-27-25Downgrade Argus Buy → Hold
Jan-08-25Upgrade TD Cowen Hold → Buy $86 → $90
Dec-09-24Upgrade Jefferies Hold → Buy $85 → $91
Jun-12-24Upgrade Citigroup Sell → Neutral $68 → $69
Apr-02-24Upgrade Argus Hold → Buy
Feb-01-24Initiated Citigroup Sell $60
Jan-22-24Downgrade Consumer Edge Research Overweight → Equal Weight
Sep-22-23Initiated HSBC Securities Hold $86
Oct-11-25 04:51PM
Oct-09-25 09:59AM
Oct-08-25 05:34AM
01:30AM
Oct-07-25 03:01PM
02:27PM Loading…
02:27PM
12:16PM
11:54AM
09:44AM
09:30AM
08:49AM
08:22AM
07:40AM
07:11AM
07:05AM
06:40AM Loading…
06:40AM
06:37AM
06:30AM
Oct-06-25 07:00PM
08:30AM
Oct-05-25 11:00PM
02:00PM
07:37AM
Oct-03-25 07:00PM
Oct-02-25 10:00AM
09:15AM
Oct-01-25 01:45PM
08:40AM
Sep-30-25 04:45PM
10:00AM
11:32AM Loading…
Sep-29-25 11:32AM
12:37AM
Sep-26-25 11:48AM
Sep-25-25 11:31PM
08:18AM
Sep-24-25 11:37PM
11:42AM
Sep-23-25 12:03AM
Sep-22-25 04:00AM
Sep-19-25 04:00AM
Sep-18-25 05:10PM
08:35AM
05:00AM
Sep-17-25 08:10AM
Sep-09-25 04:40PM
Aug-31-25 12:31AM
Aug-29-25 05:00AM
Aug-27-25 11:43AM
Aug-25-25 12:47AM
Aug-23-25 05:25AM
Aug-21-25 05:51PM
03:17PM
03:13PM
11:36AM
09:47AM
06:30AM
Aug-16-25 11:47PM
Aug-14-25 04:30PM
Aug-13-25 09:27AM
06:55AM
Aug-10-25 12:00AM
Aug-07-25 07:30AM
Jul-29-25 11:35AM
Jul-25-25 11:30AM
Jul-22-25 09:00AM
12:35AM
Jul-17-25 09:55AM
Jul-15-25 07:21PM
12:55AM
Jul-10-25 01:59PM
11:48AM
Jul-08-25 11:24AM
Jul-03-25 08:47AM
Jul-02-25 07:19AM
Jul-01-25 11:24AM
09:27AM
07:32AM
07:00AM
Jun-30-25 10:00AM
09:15AM
Jun-29-25 01:38PM
Jun-27-25 01:00PM
12:21PM
11:46AM
10:55AM
09:22AM
03:00AM
Jun-26-25 04:35PM
12:49PM
12:42PM
12:23PM
11:27AM
11:18AM
11:09AM
10:17AM
09:30AM
08:29AM
07:40AM
07:33AM
07:15AM
McCormick & Co., Inc. engages in the manufacturing, marketing, and distribution of spices, seasoning mixes, condiments, and other flavorful products to retail outlets, food manufacturers, and foodservice businesses. It operates through the Consumer and Flavor Solutions segments. The Consumer segment sells spices, seasonings, condiments, and sauces. The Flavor Solutions segment includes seasoning blends, spices and herbs, condiments, coating systems, and compound flavors. The company was founded by Willoughby M. McCormick in 1889 and is headquartered in Baltimore, MD.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Kurzius Lawrence Erik10% OwnerOct 08 '25Option Exercise49.9650,0002,498,000296,762Oct 10 09:40 AM
Kurzius Lawrence Erik10% OwnerOct 08 '25Sale65.8650,0003,293,000246,762Oct 10 09:40 AM
Schwartz Jeffery DVice President, Gen CounselJul 01 '25Option Exercise49.9610,000499,60083,957Jul 02 10:25 AM
Jenkins KatherineChief Growth OfficerMay 12 '25Option Exercise49.625,430269,4133,430May 13 03:17 PM
Jenkins KatherineChief Growth OfficerMay 12 '25Sale76.387,642583,6960May 13 03:17 PM
Repas GregoryV.P. & ControllerApr 03 '25Sale81.422,750223,9052,266Apr 04 12:13 PM
Kurzius Lawrence ErikDirectorApr 02 '25Option Exercise49.9650,0002,498,000297,437Apr 02 02:43 PM
Kurzius Lawrence ErikDirectorApr 02 '25Sale81.8150,0004,090,300247,437Apr 02 02:43 PM
Montiel Maritza GomezDirectorApr 01 '25Option Exercise52.985,912313,18812,850Apr 02 02:41 PM
Montiel Maritza GomezDirectorApr 01 '25Sale82.675,912488,7456,938Apr 02 02:41 PM
Schwartz Jeffery DVice President, Gen CounselMar 31 '25Option Exercise49.9620,000999,20089,958Apr 01 01:19 PM
Jenkins KatherineChief Growth OfficerMar 15 '25Option Exercise0.0058402,309Mar 18 06:32 PM
Gabriel Marcos MendesExecutive VP & CFOMar 15 '25Option Exercise0.001,06909,641Mar 18 06:32 PM
Sanchez AnaPresident EMEAMar 15 '25Option Exercise0.0064805,441Mar 18 06:25 PM
Tapiero JacquesDirectorMar 15 '25Option Exercise0.001,344030,446Mar 18 06:23 PM
Repas GregoryV.P. & ControllerMar 15 '25Option Exercise0.0071105,105Mar 18 06:20 PM
Kurzius Lawrence ErikDirectorMar 15 '25Option Exercise0.001,7340248,079Mar 18 06:18 PM
Piper SarahChief Human Relations OfficerMar 15 '25Option Exercise0.0021203,331Mar 18 06:14 PM
Foust AndrewPresident, AmericasMar 15 '25Option Exercise0.0093108,858Mar 18 06:12 PM
THOMAS TERRY SDirectorMar 15 '25Option Exercise0.001,34401,734Mar 18 06:10 PM
Montiel Maritza GomezDirectorMar 15 '25Option Exercise0.001,34406,938Mar 18 06:08 PM
PRESTON MARGARET M VDirectorMar 15 '25Option Exercise0.001,344081,293Mar 18 06:07 PM
Conway Michael AaronDirectorMar 15 '25Option Exercise0.001,344016,630Mar 18 06:04 PM
BRAMMAN ANNE LDirectorMar 15 '25Option Exercise0.001,34406,639Mar 18 06:01 PM
MANGAN MICHAEL DDirectorMar 15 '25Option Exercise0.001,344041,780Mar 18 05:59 PM
LITTLE PATRICIA ADirectorMar 15 '25Option Exercise0.001,344026,076Mar 18 05:58 PM
VERNON W ANTHONYDirectorMar 15 '25Option Exercise0.001,344011,826Mar 18 05:56 PM
RODKIN GARY MDirectorMar 15 '25Option Exercise0.001,344012,110Mar 18 05:54 PM
PRESTON MARGARET M VDirectorFeb 13 '25Sale77.0328,0922,163,9276,177Feb 14 10:12 AM
Tapiero JacquesDirectorFeb 03 '25Option Exercise78.0370755,16329,102Feb 04 03:30 PM
Kurzius Lawrence ErikDirectorFeb 03 '25Option Exercise49.9650,0002,498,000326,895Feb 04 03:15 PM
Kurzius Lawrence ErikDirectorFeb 03 '25Sale76.8150,0003,840,320276,895Feb 04 03:15 PM
Tapiero JacquesDirectorNov 11 '24Option Exercise38.155,000190,72533,217Nov 12 12:58 PM
Tapiero JacquesDirectorNov 11 '24Sale77.345,000386,70228,217Nov 12 12:58 PM
MANGAN MICHAEL DDirectorNov 06 '24Option Exercise38.155,000190,72545,436Nov 08 08:35 AM
MANGAN MICHAEL DDirectorNov 06 '24Sale79.005,000395,00040,436Nov 08 08:35 AM
Tapiero JacquesDirectorNov 04 '24Option Exercise38.155,000190,72533,217Nov 05 10:59 AM
Tapiero JacquesDirectorNov 04 '24Sale78.335,000391,67228,217Nov 05 10:59 AM
MANGAN MICHAEL DDirectorNov 01 '24Option Exercise38.155,000190,72545,436Nov 04 12:50 PM
MANGAN MICHAEL DDirectorNov 01 '24Sale78.505,000392,50040,436Nov 04 12:50 PM
Last Close
Oct 13  •  04:00PM ET
69.30
Dollar change
+0.93
Percentage change
1.36
%
COO Cooper Companies, Inc daily Stock Chart
IndexS&P 500 P/E34.12 EPS (ttm)2.03 Insider Own0.63% Shs Outstand198.80M Perf Week-1.16%
Market Cap13.78B Forward P/E15.73 EPS next Y4.41 Insider Trans1.46% Shs Float197.56M Perf Month3.93%
Enterprise Value16.13B PEG3.66 EPS next Q1.11 Inst Own101.88% Short Float3.89% Perf Quarter-4.02%
Income407.80M P/S3.41 EPS this Y10.99% Inst Trans0.91% Short Ratio2.96 Perf Half Y-10.53%
Sales4.05B P/B1.65 EPS next Y7.58% ROA3.33% Short Interest7.69M Perf YTD-24.62%
Book/sh42.02 P/C110.31 EPS next 5Y9.31% ROE5.01% 52W High109.37 -36.64% Perf Year-35.11%
Cash/sh0.63 P/FCF33.45 EPS past 3/5Y-49.03% -3.45% ROIC3.78% 52W Low61.78 12.18% Perf 3Y2.85%
Dividend Est.0.01 (0.02%) EV/EBITDA14.52 Sales past 3/5Y10.05% 7.98% Gross Margin62.03% Volatility2.42% 2.48% Perf 5Y-18.95%
Dividend TTM- EV/Sales3.99 EPS Y/Y TTM12.94% Oper. Margin18.31% ATR (14)1.79 Perf 10Y87.07%
Dividend Ex-DateJul 26, 2023 Quick Ratio1.24 Sales Y/Y TTM6.35% Profit Margin10.08% RSI (14)51.69 Recom1.95
Dividend Gr. 3/5Y- - Current Ratio2.12 EPS Q/Q-5.82% SMA201.62% Beta1.01 Target Price82.19
Payout0.00% Debt/Eq0.30 Sales Q/Q5.73% SMA50-0.24% Rel Volume1.14 Prev Close68.37
Employees16000 LT Debt/Eq0.29 EarningsAug 27 AMC SMA200-11.95% Avg Volume2.60M Price69.30
IPOJan 21, 1983 Option/ShortYes / Yes EPS/Sales Surpr.3.23% -0.34% Trades Volume2,970,537 Change1.36%
Date Action Analyst Rating Change Price Target Change
TodayInitiated Barclays Overweight $85
Oct-01-25Initiated Goldman Sell $64
Aug-28-25Downgrade Citigroup Buy → Neutral $72
Jul-22-25Upgrade BNP Paribas Exane Neutral → Outperform $92
Jun-17-25Upgrade Needham Hold → Buy $94
May-30-25Downgrade JP Morgan Overweight → Neutral $76
Aug-29-24Reiterated Piper Sandler Overweight $115 → $120
Jul-16-24Upgrade Jefferies Hold → Buy $107 → $115
Mar-19-24Upgrade Redburn Atlantic Neutral → Buy $125
Mar-13-24Upgrade JP Morgan Neutral → Overweight $100 → $120
Oct-01-25 11:01AM
Sep-26-25 11:30AM
12:39AM
Sep-22-25 09:46AM
Sep-19-25 01:55AM
11:42AM Loading…
Sep-18-25 11:42AM
Sep-17-25 04:15PM
Sep-15-25 09:40AM
Sep-09-25 12:02AM
Sep-03-25 01:31AM
Sep-02-25 03:30PM
Sep-01-25 09:15AM
Aug-31-25 11:34PM
Aug-29-25 09:47AM
09:40AM
05:28PM Loading…
Aug-28-25 05:28PM
04:25PM
04:05PM
11:48AM
11:30AM
11:20AM
11:12AM
09:50AM
09:39AM
05:46AM
05:10AM
03:06AM
Aug-27-25 06:00PM
05:25PM
04:49PM
04:15PM Loading…
04:15PM
Aug-26-25 06:42PM
11:40AM
09:55AM
08:22AM
Aug-25-25 11:02PM
09:51AM
Aug-22-25 09:15AM
Aug-20-25 10:00AM
Aug-19-25 08:50AM
Aug-14-25 05:30PM
04:15PM
Aug-12-25 10:58AM
08:13AM
Aug-11-25 08:28AM
Aug-07-25 07:40AM
Aug-06-25 05:25PM
Aug-05-25 12:16PM
12:00PM
11:40AM
07:36AM
12:00AM
Jul-31-25 08:50AM
Jul-25-25 07:55AM
Jul-24-25 04:15PM
Jul-22-25 11:56AM
Jul-14-25 06:20AM
Jul-02-25 08:21AM
Jul-01-25 01:32AM
Jun-23-25 11:31PM
09:32AM
Jun-19-25 11:20AM
Jun-18-25 09:51AM
Jun-07-25 09:47AM
Jun-05-25 05:37PM
Jun-03-25 09:45AM
Jun-02-25 09:40AM
09:15AM
08:43AM
May-30-25 08:47PM
02:13PM
12:41PM
11:59AM
11:40AM
09:32AM
03:08AM
May-29-25 09:10PM
06:00PM
05:30PM
04:51PM
04:30PM
04:15PM
09:29AM
May-28-25 03:03AM
May-23-25 09:15AM
May-22-25 09:18AM
May-20-25 04:15PM
07:48AM
May-15-25 06:35PM
May-14-25 11:40AM
07:47AM
May-12-25 07:33PM
May-08-25 04:15PM
07:10AM
12:36AM
May-07-25 05:45PM
May-06-25 09:45AM
May-01-25 07:55AM
Apr-30-25 04:15PM
Apr-29-25 04:15PM
The Cooper Cos, Inc. operates as a medical device company. It operates through the Cooper Vision and Cooper Surgical segments. The Cooper Vision segment develops, manufactures, and markets products for contact lens wearers, which solves vision challenges such as astigmatism, presbyopia, myopia, ocular dryness, and eye fatigues. The Cooper Surgical segment focuses on the provision of advancement for the health of women, babies, and families through women's health and fertility products and services. The company was founded in 1958 and is headquartered in San Ramon, CA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Kurzius Lawrence ErikDirectorSep 29 '25Buy68.392,000136,7805,777Sep 29 08:36 PM
White Albert G IIIPresident & CEOSep 05 '25Buy68.3910,000683,900226,151Sep 05 05:10 PM
Warner Gerard H IIIPresident, CooperVision, Inc.Sep 05 '25Buy69.231,450100,38418,319Sep 05 04:07 PM
McBride Daniel GEVP & Chief Operating OfficerSep 02 '25Buy65.043,000195,12063,120Sep 02 05:17 PM
Andrews Brian GEVP, CFO & TreasurerSep 02 '25Buy65.681,525100,16222,191Sep 02 05:16 PM
KOZY WILLIAM ADirectorApr 01 '25Option Exercise0.002,857031,149Apr 03 04:09 PM
WEISS ROBERT SDirectorApr 01 '25Option Exercise0.002,9930288,945Apr 03 04:09 PM
Rivas MariaDirectorApr 01 '25Option Exercise0.002,72102,721Apr 03 04:08 PM
MADDEN TERESA SDirectorApr 01 '25Option Exercise0.002,721012,357Apr 03 04:08 PM
Lucchese Cynthia LDirectorApr 01 '25Option Exercise0.002,72107,661Apr 03 04:07 PM
Kurzius Lawrence ErikDirectorApr 01 '25Option Exercise0.002,72103,777Apr 03 04:07 PM
Jay ColleenDirectorApr 01 '25Option Exercise0.002,721029,521Apr 03 04:06 PM
Ricupati AgostinoSVP & CAOApr 01 '25Option Exercise0.002,07609,044Apr 03 04:06 PM
McBride Daniel GEVP & Chief Operating OfficerFeb 01 '25Option Exercise0.0022,777071,687Feb 04 04:25 PM
White Albert G IIIPresident & CEOFeb 01 '25Option Exercise0.0084,2640258,941Feb 04 04:25 PM
Andrews Brian GEVP, CFO & TreasurerFeb 01 '25Option Exercise0.0016,850023,464Feb 04 04:24 PM
Sheffield Holly RPresident, CSIFeb 01 '25Option Exercise0.0017,309045,843Feb 04 04:24 PM
White Albert G IIIPresident & CEOJan 08 '25Option Exercise0.0018,3400183,613Jan 10 04:12 PM
Warner Gerard H IIIPresident, CooperVision, Inc.Jan 08 '25Option Exercise0.0013,328023,763Jan 10 04:12 PM
Sheffield Holly RPresident, CSIJan 08 '25Option Exercise0.004,900030,898Jan 10 04:11 PM
Ricupati AgostinoSVP & CAOJan 08 '25Option Exercise0.004,47209,328Jan 10 04:11 PM
McBride Daniel GEVP & Chief Operating OfficerJan 08 '25Option Exercise0.008,728053,424Jan 10 04:11 PM
Andrews Brian GEVP, CFO & TreasurerJan 08 '25Option Exercise0.006,420013,034Jan 10 04:10 PM
Khadder NicholasVP, General Counsel & Corp SecJan 08 '25Option Exercise0.003,49204,369Jan 10 04:10 PM
ELAN Elanco Animal Health Inc daily Stock Chart
Index- P/E22.96 EPS (ttm)0.87 Insider Own0.97% Shs Outstand496.65M Perf Week-3.00%
Market Cap9.96B Forward P/E20.03 EPS next Y1.00 Insider Trans0.00% Shs Float492.01M Perf Month8.15%
Enterprise Value13.63B PEG2.94 EPS next Q0.13 Inst Own108.59% Short Float5.90% Perf Quarter37.17%
Income434.00M P/S2.22 EPS this Y-1.65% Inst Trans7.95% Short Ratio4.09 Perf Half Y132.48%
Sales4.48B P/B1.47 EPS next Y11.78% ROA3.16% Short Interest29.02M Perf YTD65.48%
Book/sh13.64 P/C18.47 EPS next 5Y7.80% ROE6.83% 52W High21.76 -7.90% Perf Year37.35%
Cash/sh1.08 P/FCF27.58 EPS past 3/5Y- 29.95% ROIC3.97% 52W Low8.02 149.88% Perf 3Y58.42%
Dividend Est.- EV/EBITDA15.61 Sales past 3/5Y-2.33% 7.65% Gross Margin42.98% Volatility3.38% 3.10% Perf 5Y-29.01%
Dividend TTM- EV/Sales3.04 EPS Y/Y TTM134.46% Oper. Margin4.66% ATR (14)0.61 Perf 10Y-
Dividend Ex-Date- Quick Ratio1.40 Sales Y/Y TTM-0.18% Profit Margin9.68% RSI (14)58.86 Recom1.67
Dividend Gr. 3/5Y- - Current Ratio2.60 EPS Q/Q121.94% SMA201.94% Beta1.70 Target Price21.36
Payout0.00% Debt/Eq0.62 Sales Q/Q4.81% SMA509.02% Rel Volume0.63 Prev Close19.76
Employees9450 LT Debt/Eq0.61 EarningsNov 05 BMO SMA20047.42% Avg Volume7.09M Price20.04
IPOSep 20, 2018 Option/ShortYes / Yes EPS/Sales Surpr.30.85% 4.64% Trades Volume4,431,633 Change1.42%
Date Action Analyst Rating Change Price Target Change
Oct-07-25Upgrade JP Morgan Neutral → Overweight $24
Jul-17-25Upgrade Leerink Partners Market Perform → Outperform $18
Jun-26-25Upgrade William Blair Mkt Perform → Outperform
Dec-09-24Initiated UBS Buy $18
Dec-02-24Initiated Leerink Partners Market Perform $14
Sep-19-24Downgrade Morgan Stanley Overweight → Equal-Weight $17 → $15
Jan-05-24Upgrade Stifel Hold → Buy $13 → $20
Dec-19-23Initiated Jefferies Buy $17
Dec-15-23Upgrade Morgan Stanley Equal-Weight → Overweight $16
Dec-07-23Initiated Exane BNP Paribas Outperform $18
Oct-08-25 12:00PM
Oct-07-25 11:31AM
Oct-06-25 11:40AM
05:15AM
Oct-01-25 08:00AM
12:00PM Loading…
Sep-30-25 12:00PM
Sep-24-25 12:01PM
Sep-23-25 07:10PM
06:27AM
Sep-11-25 10:57PM
Sep-08-25 03:35PM
06:27AM
Sep-03-25 02:45PM
Sep-01-25 11:31PM
Aug-27-25 12:31PM
08:00AM Loading…
08:00AM
Aug-26-25 06:15PM
08:00AM
Aug-14-25 01:34AM
Aug-12-25 03:25AM
Aug-08-25 06:57PM
11:53AM
Aug-07-25 02:13PM
12:23PM
09:30AM
07:35AM
06:59AM
06:27AM
Aug-06-25 06:15PM
09:15AM
11:11PM Loading…
Aug-05-25 11:11PM
Aug-04-25 05:45PM
Jul-31-25 01:16PM
Jul-25-25 03:36PM
Jul-24-25 05:42PM
11:40AM
Jul-22-25 09:40AM
Jul-21-25 04:11AM
Jul-17-25 09:46AM
Jul-15-25 10:35AM
Jul-10-25 08:00AM
Jul-09-25 08:27AM
Jul-02-25 07:00AM
Jun-30-25 07:25AM
Jun-26-25 01:00PM
09:49AM
Jun-18-25 12:46PM
Jun-12-25 04:17PM
Jun-11-25 04:25AM
Jun-10-25 12:00PM
11:40AM
09:40AM
Jun-09-25 08:48AM
Jun-05-25 07:45AM
May-28-25 11:00AM
07:25AM
May-20-25 12:00AM
May-16-25 08:00AM
May-12-25 06:45PM
May-08-25 03:09AM
01:47AM
May-07-25 12:53PM
12:52PM
09:30AM
08:36AM
07:35AM
06:27AM
May-05-25 04:40PM
06:27AM
May-01-25 10:01AM
Apr-30-25 10:01AM
Apr-28-25 09:07AM
Apr-23-25 05:45PM
12:24PM
Apr-22-25 12:50PM
11:25AM
Apr-10-25 11:34AM
08:00AM
Apr-08-25 10:30AM
Apr-04-25 10:00AM
Mar-31-25 07:33AM
Mar-28-25 04:55PM
Mar-26-25 11:02AM
Mar-21-25 07:52AM
Mar-19-25 10:27AM
Mar-18-25 05:01AM
Mar-17-25 04:17PM
Mar-14-25 05:03AM
Mar-13-25 08:44AM
Mar-11-25 11:05PM
Feb-26-25 06:09PM
02:05AM
12:34AM
Feb-25-25 01:38PM
01:15PM
09:30AM
08:20AM
07:15AM
07:05AM
07:05AM
Elanco Animal Health, Inc. develops, manufactures, and markets products for pets and farm animals. Its products include Advantage Family, Atopica, Credelio Family, Drontal Family, Galliprant, Interceptor Plus, Milbemax, Onsior, Seresto, Trifexis, TruCan, AviPro, Baytril, Catosal, Denagard, and Experior. The company was founded in 1954 and is headquartered in Greenfield, IN.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Todd S and Jennifer G Young LiFormer CFOAug 11 '25Proposed Sale16.8249,333830,000Aug 11 03:58 PM
Kurzius Lawrence ErikDirectorMar 07 '25Buy10.9010,000109,000101,459Mar 11 05:13 PM
Kurzius Lawrence ErikDirectorMar 11 '25Buy10.2010,000102,000111,459Mar 11 05:13 PM
HOOVER R DAVIDDirectorMar 05 '25Buy10.9025,000272,558210,000Mar 07 04:21 PM